STEMCELLS, INC.

5 Biotech Stocks Poised for Breakouts

Can Stem Cells Regenerate Your Portfolio? Stephen Dunn Says Yes

StemCells, Inc. Achieves Spinal Cord Injury Milestone With First Neural Stem Cell Transplant Into P

StemCells says first patient with incomplete spinal injury enrolled in trial

StemCells, Inc. Achieves Spinal Cord Injury Milestone With First Neural Stem Cell Transplant Into Patient With Sensory Function Below the Level of Injury

StemCells, Inc. to Present at Neurodegenerative Conditions Research and Development Conference

StemCells falls 3.4%

StemCells, Inc. Provides Additional Comments on Recent Awards From the California Institute for Regenerative Medicine

Biotech Industry Looks to Benefit From New Legislation Passed to Help Speed Up FDA Review Process

A tiny step forward for spinal cord injuries